Summary of findings: Folic acid vs placebo
Haematological disorders (neutropenia, etc) · Patients receiving methotrexate for rheumatoid arthritis
Folic acid showed no clear difference in haematological disorders (incidence of neutropenia, etc) compared with placebo (low certainty).
1 finding from 1 review
- Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis 2013 · Cochrane Headline outcomes onlyRR 1.7 [0.42, 6.96]2 studies · 443 participantsLow